CNS Pharmaceuticals Inc. (CNSP)
NASDAQ: CNSP
· Real-Time Price · USD
4.96
-1.07 (-17.74%)
At close: Aug 15, 2025, 3:59 PM
5.43
9.48%
After-hours: Aug 15, 2025, 07:47 PM EDT
CNS Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.21 | -10.47 | -6.43 | -339.43 | -3.9K | -9.09K | -13.11K | -26.77K | -4.81K | -8.06K | -25.42K | -38.13K | -50.51K | -79.78K | -131.31K | -153.57K | -197.63K |
PEG Ratio | 0.01 | -0.01 | 0.06 | -4.49 | -0.39 | 124.25 | -3.41K | 447.31 | 35.62 | 0.97 | n/a | -1.33K | 502.43 | 8.46 | 19.7K | n/a | 1.95K |
PS Ratio | n/a | 42.36K | n/a | n/a | n/a | 30.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.34 | 21.53 | 43.03 | -800.28 | -12.5K | -44.09K | -136.23K | 175.43K | 27.19K | 21.81K | 41.42K | 47.19K | 43.02K | 134.7K | 220.16K | 188.8K | 254.08K |
P/FCF Ratio | -1.14 | -24.29 | -21.21 | -2.08K | -17.34K | -76.98K | -70.2K | -126.54K | -19.68K | -76.93K | -191.62K | -161.59K | -206.95K | -275.4K | -1M | -468.71K | -862.55K |
P/OCF Ratio | -1.14 | -24.31 | -21.21 | -2.08K | -17.34K | -77.05K | -70.24K | -126.54K | -19.68K | -76.93K | -191.78K | -161.73K | -206.95K | -275.57K | -1M | -468.71K | -863.51K |
OCF/S Ratio | n/a | -1.74K | n/a | n/a | n/a | -398.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.05 | 0.01 | -0.03 | -0.05 | -0.07 | -0.02 | 0.07 | 0.08 | 0.05 | 0.00 | 0.01 | 0.02 | 0.06 | 0.00 | 0.01 | 0.03 |
Quick Ratio | 4.94 | 3.43 | 1.82 | 0.32 | 0.26 | 0.26 | 0.51 | 1.52 | 1.78 | 2.55 | 6.99 | 12.34 | 13.78 | 3.50 | 4.63 | 7.58 | 6.72 |
Current Ratio | 4.94 | 3.43 | 1.82 | 0.32 | 0.26 | 0.26 | 0.51 | 1.52 | 1.78 | 2.55 | 6.99 | 12.34 | 13.78 | 3.50 | 4.63 | 7.58 | 6.72 |
Asset Turnover | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -698.72 | -1.15K | -2.49K | -566.47 | -535.07 | -1.87K | -2.47K | -1.1K | -906.28 | -2.38K | -6.36K | -2.21K | -1.08K | -1.25K | -4.03K | -1.62K | -963.35 |
Return on Equity | -0.39 | -0.51 | -1.67 | 0.59 | 0.80 | 1.21 | 2.60 | -1.64 | -1.41 | -0.68 | -0.41 | -0.31 | -0.21 | -0.42 | -0.42 | -0.31 | -0.32 |
Return on Assets | -0.31 | -0.37 | -0.76 | -1.02 | -2.13 | -3.16 | -1.94 | -0.62 | -0.67 | -0.42 | -0.35 | -0.29 | -0.2 | -0.32 | -0.33 | -0.27 | -0.27 |
Return on Invested Capital | -0.39 | -0.49 | -1.66 | 0.61 | 0.84 | 1.37 | 2.67 | -1.54 | -1.3 | -0.64 | -0.41 | -0.31 | -0.18 | -0.4 | -0.42 | -0.3 | -0.31 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.50 | n/a | n/a | n/a | 0.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -1.01K | n/a | n/a | n/a | -844.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -1.01K | n/a | n/a | n/a | -844.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -1.02K | n/a | n/a | n/a | -845.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -1.01K | n/a | n/a | n/a | -844.3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |